Moneycontrol
HomeNewsBusinessCOVID-19 impact | Paid OTT subscriptions rise nearly 60% to 100-125 million in 2020: Report
Trending Topics

COVID-19 impact | Paid OTT subscriptions rise nearly 60% to 100-125 million in 2020: Report

In 2020, the the number of paid OTT subscriptions (also known as SVoD) increased to about 100-125 million, up by nearly 55-60 per cent from 49 million subscriptions in 2018, said a CII-BCG report.

December 16, 2020 / 21:28 IST
Story continues below Advertisement

The adoption of subscription video-on-demand (SVoD) services picked up in 2020 as consumers spent more time at home in the wake of the COVID-19 pandemic-induced lockdown.

The consumption surged in both smartphones and TV.

Story continues below Advertisement

In 2020, the the number of paid OTT subscriptions (also known as SVoD) increased to about 100-125 million, up by nearly 55-60 per cent from 49 million subscriptions in 2018, said a CII-BCG report.

The report also claimed that the rise in the number of paid OTT subscriptions could be attributed to the low-ticket size plans by OTT players and enhanced ease of payments.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show